NIP
CDLX icon

Nicholas Investment Partners’s Cardlytics CDLX Stock Holding History

Nicholas Investment Partners’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,841
Closed -$1.01M – 184
2022
Q1 		$1.01M Buy
1,841
+184
+11% +$111K 0.07% 167
2021
Q4 		$1.09M Sell
1,657
-2,402
-59% -$1.84M 0.07% 175
2021
Q3 		$3.41M Sell
4,059
-2,042
-33% -$2.07M 0.25% 128
2021
Q2 		$7.74M Sell
6,101
-398
-6% -$449K 0.49% 74
2021
Q1 		$7.13M Buy
6,499
+478
+8% +$631K 0.5% 67
2020
Q4 		$8.6M Buy
6,021
+487
+9% +$519K 0.66% 54
2020
Q3 		$3.9M Buy
5,534
+106
+2% +$77.1K 0.42% 74
2020
Q2 		$3.8M Sell
5,428
-902
-14% -$521K 0.77% 36
2020
Q1 		$2.21M Sell
6,330
-679
-10% -$481K 0.43% 92
2019
Q4 		$4.41M Sell
7,009
-9,968
-59% -$4.87M 0.45% 73
2019
Q3 		$5.69M Buy
16,977
+7,774
+84% +$2.49M 0.48% 70
2019
Q2 		$2.39M Buy
+9,203
New +$1.84M 0.22% 150

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nicholas Investment Partners's CDLX Position: Q2 2022 in Review

Nicholas Investment Partners sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 1,841 shares — an estimated $1.01M sold.

Nicholas Investment Partners first reported a position in CDLX in Q2 2019 and held it in 12 quarters. The position peaked at $8.6M in Q4 2020. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • Nicholas Investment Partners reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 1,841 Cardlytics shares in Q2 2022, an estimated $1.01M.
  • Nicholas Investment Partners first reported a position in Cardlytics in Q2 2019 and held it in 12 quarters.
  • Nicholas Investment Partners's Cardlytics position peaked at $8.6M in Q4 2020.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on Nicholas Investment Partners's 13F filing for Q2 2022, filed 10 Aug 2022.